Skip to main content
. 2016 Nov 22;7(52):87081–87090. doi: 10.18632/oncotarget.13499

Figure 3. TCF21 is a positive biomarker in lung cancer prognosis.

Figure 3

A. The GEO database GSE31210 was employed to analyze the prognosis of lung cancer patients with high or low expression of TCF21 (TCF21 low expression group, n=120; TCF21 high expression group, n=102). B. The Kaplan Meier plotter was employed to analyze the prognosis of lung cancer patients by TCF21 (TCF21 low expression group, n=572; TCF21 high expression group, n=573).